| Verified against primary record | |
| United States statutory wording | "Reasonable and necessary", under section 1862(a)(1)(A) of the Social Security Act, which the statute does not define[1] |
|---|---|
| Current regulatory position | No definition of reasonable and necessary or medically necessary appears in the Medicare regulation; the terms defined there concern investigational devices and trials[2] |
| England’s equivalent language | Access on the basis of clinical need, with a right to treatments a clinician considers clinically appropriate. The phrase medical necessity does not appear[3] |
| Independently reported | |
| Germany’s equivalent test | Benefits must be sufficient, appropriate and economical and must not exceed what is necessary[4] |
| Bands apply only to the rows beneath them. The German provision was read in a private reproduction of the statute because the official text could not be retrieved, and is placed in the lower band for that reason. | |
Medical necessity is the test a payer applies to decide whether it will fund a treatment. It is not a clinical standard, it is not defined uniformly in any legal system examined here, and it does not operate at all for a patient paying a foreign provider directly, which is the position most medical travellers are in.
No single definition in United States law
The phrase most people mean by medical necessity is not the phrase the statute uses. Section 1862(a)(1)(A) of the Social Security Act permits Medicare payment for items or services that are reasonable and necessary for the diagnosis or treatment of illness or injury, or to improve the functioning of a malformed body member, and does not define the expression.[1]
A regulatory definition existed briefly. A rule finalised in January 2021 added one to the Medicare regulations; in September 2021 the agency proposed to remove it, noting that the definition mirrored a longstanding manual formulation with a modified appropriateness factor addressing the use of commercial insurer coverage policies;[1] and in November 2021 the agency repealed it, on the stated ground that it might not adequately protect Medicare patients and that breakthrough-device studies may not reflect the Medicare population.[5] The current regulation accordingly contains no such definition: the terms defined in the relevant subpart concern experimental and non-experimental device categories, investigational device exemptions, trial registration and routine care items, and the reasonable-and-necessary standard is invoked only by citing the statute.[2]
What exists instead is process. A national coverage determination begins with a posted tracking sheet, proceeds through evidence review and optionally an advisory committee meeting, requires a proposed determination about six months later or nine where an external assessment or committee meeting is involved, runs a statutory 30-day comment period and a final decision within 60 days of its close, taking nine to twelve months overall; reconsideration requires new evidence or a plausible argument that the original reading of the evidence was wrong.[6] Necessity is therefore determined case by case and payer by payer rather than by a definition.
The crisp wording that circulates most widely, health care services or supplies needed to diagnose or treat an illness, injury, condition, disease or its symptoms and meeting accepted standards of medicine, comes from an undated consumer glossary on a federally operated website, not from a statute or regulation.[7]
Other systems use other language
England does not use the term. The NHS Constitution for England frames access on clinical need rather than ability to pay, gives patients a right to treatments recommended by the national guidance body where a clinician considers them clinically appropriate, and sets out rights to certain services within maximum waiting times with reasonable steps to offer alternative providers where those are breached.[3]
Germany embeds a different test in social law. Statutory health insurance benefits must be sufficient, appropriate and economical and must not exceed what is necessary, and benefits that are unnecessary or uneconomical may not be claimed by insured persons, provided by practitioners or approved by sickness funds.[4] That is an economy requirement combined with a necessity requirement, and it is not a translation of the American term. Treating the three as equivalents is a mistake: they sit in different legal orders with different adjudicators.
Why none of it reaches the self-paying traveller
Every necessity standard located in this work is a payer gatekeeping standard: Medicare coverage, statutory insurance benefit scope, or domestic commissioning. No requirement for necessity review was found that attaches to a patient who funds treatment themselves and contracts directly with a provider in another country. That is reported here as a negative finding rather than inferred from any authority. Its practical effect is that the question a home system would ask, whether this operation is indicated at all, is not asked anywhere in the transaction, and the only remaining filter is the provider’s own assessment, which is also the party being paid.
A related confusion is worth separating out. Because treatment travel is almost always elective in the administrative sense, it is sometimes described as not medically necessary. Those are different axes: an operation can be scheduled in advance and still be indicated, as Australian practice states explicitly.
See also
- Elective Surgery, the administrative category frequently mistaken for a necessity judgement
- Clinical Referral, the gatekeeping act that necessity review usually accompanies
- Shared Decision-Making, what is supposed to happen where necessity is genuinely a matter of judgement
- Self-Funded Medical Travel, the position in which no payer applies a necessity test at all
References
- Centers for Medicare and Medicaid Services. Medicare Program; Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary (proposed repeal). 86 FR 51326, 15 September 2021. Verified against primary record: the Federal Register document was opened and the statutory citation and the account of the definition proposed for removal read. Retrieved 10 October 2026.
- Office of the Federal Register. Electronic Code of Federal Regulations, 42 CFR part 405 subpart B. Source note last amended 86 FR 62958, 15 November 2021. Verified against primary record: the subpart was opened and its defined terms inspected for any definition of reasonable and necessary or medically necessary. Retrieved 10 October 2026.
- Department of Health and Social Care. The NHS Constitution for England. Updated 17 August 2023. Verified against primary record: the Constitution was opened and its principles and rights read, and checked for the phrase medical necessity. Retrieved 10 October 2026.
- Sozialgesetzbuch, Fuenftes Buch, section 12 (Wirtschaftlichkeitsgebot). Read at lxgesetze.de, a private reproduction, last amendment shown 24 July 2026. Independently reported: the official text at gesetze-im-internet.de could not be retrieved, so this provision rests on a single unofficial reproduction and should be confirmed against the official text before being relied on.
- Centers for Medicare and Medicaid Services. CMS repeals the Medicare Coverage of Innovative Technology and Reasonable and Necessary rule. 12 November 2021. Verified against primary record: the press release was opened and the stated grounds for repeal read. Retrieved 10 October 2026.
- Centers for Medicare and Medicaid Services. National Coverage Determination Process and Timeline. Page last modified 10 March 2026. Verified against primary record: the page was opened and the procedural steps and statutory deadlines read. Retrieved 10 October 2026.
- Centers for Medicare and Medicaid Services. Glossary entry: medically necessary. No publication or last-updated date on the page. Verified against primary record: the glossary entry was opened and read, and the absence of a date noted. Retrieved 10 October 2026.
Sourcing note: the German provision is the weakest-sourced item in this entry. The official federal law site could not be retrieved during this work, so the text was read in a private reproduction, and it is placed in the independently reported band and flagged in its reference accordingly. No source was located establishing any necessity-review requirement that applies to a self-funding cross-border patient, and that absence is reported as a negative finding rather than inferred.